Overall Survival and Long-Term Safety of Nivolumab (Anti-Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer (Q36352827)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q55130361)
(Q55965797)
(Q66809426)
(Q90321337)
(Q90926732)
(Q89453908)
(Q89453911)
(P304) 2004-2012
(P407) (Q1860)
(P433) 18
(P478) 33
(P577) Monday, April 20, 2015
(P921) (Q79460)
(Q47912)
(P1433) (Q400292)
(P1476) "Overall Survival and Long-Term Safety of Nivolumab (Anti-Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer" (language: en)
(P2093) Scott N Gettinger
Leora Horn
David R Spigel
Scott J Antonia
Naiyer A Rizvi
John D Powderly
Rebecca S Heist
Richard D Carvajal
David M Jackman
Philip Leming
David P Carbone
Mary C Pinder-Schenck
Jeffrey A Sosman
David F McDermott
Vindira Sankar
Christoph M Ahlers
Mark Salvati
Jon M Wigginton
Matthew D Hellmann
Georgia D Kollia
Ashok K Gupta
Julie R Brahmer
(P2860) (Q29617771)
(Q29620594)
(Q29620688)
(Q34421845)
(Q29620596)
(Q37126929)
(Q36412597)
(Q38062459)
(Q24633070)
(Q35870655)
(Q36366489)
(Q37952953)
(Q27851588)
(Q28265610)
(Q39296380)
(Q29547546)
(Q34547495)
(Q24535835)
(Q28131654)
(Q24675931)
(Q27860904)
(Q22010866)
(Q29619399)
(Q48215164)
(Q45244872)
(Q53521886)
(Q95375604)
other details
description scientific article

External Links